MR 7700 Multinuclear Application Clinical Study

Inclusion criteria

• 1. HCC patient group

• Age ≥ 18 years;
• With clear consciousness, ability to cooperate, and autonomous behavior;
• Voluntary agreement to participate in this clinical trial and signing of the subject's informed consent form;
• Patients diagnosed with primary hepatocellular carcinoma by imaging or clinical diagnosis, and who have not received tumor treatment.
• 2. Healthy control group

• Age ≥ 18 years;
• With clear consciousness, ability to cooperate, and autonomous behavior;
• Voluntary agreement to participate in this clinical trial and signing of the subject's informed consent form;
• No previous history of liver disease.

Exclusion criteria

• HCC patient group and healthy control group

• Patients with claustrophobia.
• Subject's body temperature > 39.5°C on the day of scanning.
• Females who plan to be pregnant within 6 months, and pregnant and lactating females.
• Patients with other implants, prostheses, foreign bodies, patches, etc. that are not suitable for MRI examination; patients with electronic implants, such as pacemakers, stimulators, insulin pumps, cochlear implants, etc.
• Critically ill subjects with various resuscitation devices or those with any emergency medical condition requiring first aid.
• Subjects with poor compliance are considered to be excluded by the investigators.
• Subjects who are not considered suitable for this trial by the investigators.